AU2021100766A4 - A Preparation Method of (S)-(+)-2, 2-dimethyl cyclopropanecarboxamide - Google Patents
A Preparation Method of (S)-(+)-2, 2-dimethyl cyclopropanecarboxamide Download PDFInfo
- Publication number
- AU2021100766A4 AU2021100766A4 AU2021100766A AU2021100766A AU2021100766A4 AU 2021100766 A4 AU2021100766 A4 AU 2021100766A4 AU 2021100766 A AU2021100766 A AU 2021100766A AU 2021100766 A AU2021100766 A AU 2021100766A AU 2021100766 A4 AU2021100766 A4 AU 2021100766A4
- Authority
- AU
- Australia
- Prior art keywords
- dimethyl
- acid
- cyclopropanecarboxamide
- alcohol
- cyclopropanecarboxylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/16—Preparation of optical isomers
- C07C231/18—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses a preparation method of (S)-(+)-2, 2- dimethyl
cyclopropanecarboxamide, specifically including the following steps. 1) Asymmetric
cyclopropanation. Diazoacetate and isobutene are catalyzed by a chiral ligand complex of
cuprous salt, and then (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate is obtained by
cyclopropylation. 2) Catalytic amidation of cyclopropanecarboxylate. (S)-(+)-2, 2
dimethyl cyclopropanecarboxamide is directly synthesized by one-step ammonolysis of
(S)-(+)-2, 2-dimethyl cyclopropanecarboxylate. The chemical purity of refined amide by
alcohol is higher than 99.5% and e.e. value is greater than 99.5% as well. The invention
relates to a green, environmentally friendly, simple and efficient preparation method of (S)
(+)-2, 2-dimethyl cyclopropanecarboxamide.
Description
A Preparation Method of (S)-(+)-2, 2-dimethyl cyclopropanecarboxamide
The invention belongs to the field of chemical engineering, particularly related to dimethyl
cyclopropanecarboxamide, particularly to a preparation method of (S)-(+)-2, 2- dimethyl
cyclopropanecarboxamide.
Cilastatin is an inhibitor of renal dehydropeptidase, which can improve the stability of
Imipenem in vivo. Clinical experiments show that a compound preparation of cilastatin
and Imipenem, is especially suitable for the treatment of combined infection of multiple
bacteria and mixed infection of aerobic and anaerobic bacteria. (S)-(+)-2,2- dimethyl
cyclopropanecarboxamide with the molecular formula in Fig. 1 is one of the key
intermediates in the synthesis of cilastatin. The preparation methods of (S)-(+)-2,2
dimethyl cyclopropanecarboxamide mainly include: 1) taking dimethyl malonate as the
starting material, and sequentially carrying out cyclopropanation, saponification,
hydrolysis, heating, decarboxylation and amidation reaction. The total yield of this method
is 22% [Chin. J. Org. Chem, 2008, 28 (2): 308-310], but this method can only synthesize
racemic dimethyl cyclopropanecarboxamide. 2) Isovaleric acid is used as the main starting
material, and then preparing dimethyl cyclopropanecarboxamide by esterification,
cyclopropanation, hydrolysis, esterification, salt formation, fractional crystallization and
aminolysis reaction. Although the reaction conditions of each step are mild, the process is
relatively simple, the enantiomeric excess can reach more than 95.6%. But this method has
a long reaction route with only about 12% total yield. [Tetrahederon: Asymmetry, 1998, 9
(22): 3971-3977] The resolution agents reported in the literature are D-phenylethylamine,
L-camitine oxalate, L-menthol, (S) - methyl mandelate, etc. Although these resolution
agents can resolve dimethyl cyclopropanecarboxylic acid, the yields are between 20% and
%, which are relatively low. In addition, the steps of synthesizing acyl chloride from
acid and then producing amide make the yield of amide low. 3) Synthesis of (S)-(+)-2,2
dimethyl cyclopropanecarboxamide by the biological method. Using R-amidase produced
bacteria to selectively hydrolyze (R)-2, 2-dimethyl cyclopropanecarboxamide in racemic
dimethyl cyclopropanecarboxamide. Lonza company in Switzerland has successfully
adopted this process to produce (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide [Adv.
Synth. Catal., 2003, 345 (4): 425-435.]. Through this method, the e.e. value is over 95%,
but the selective amidase is few, and the production cost is very high. 4) Using chiral metal
complexes as catalysts, dimethyl cyclopropanecarboxylate is synthesized by asymmetric
synthesis method, and the value of e.e. is up to 92% above [J. Am. Chem. Soc., 1991, 113
(2): 726-728]
In view of the drawbacks in the reported examples, the present invention provides a
preparation method of chiral dimethyl cyclopropanecarboxamide compound, which aims
to solve the technical problems of low yield and high cost of the preparation method in the
prior art.
The invention relates to a preparation method of a chiral dimethyl
cyclopropanecarboxamide compound, which comprises the following steps.
(1) Preparation of (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate. Weighing isobutylene
and diazoacetate, wherein the molar ratio of isobutylene to diazoacetate is 0.8-1.2: 0.8-1.2.
Then weighing chiral catalyst, wherein the additional amount of the chiral catalyst is 0.5
3% of the mass of isobutylene. And then the halogenated hydrocarbon solvent is measured,
and the volume ratio of halogenated hydrocarbon solvent to isobutene is 1-3: 1. Chiral
catalyst is added into a reaction vessel, then halogenated hydrocarbon solvent and
isobutene are added, and diazoacetate is finally added. Under the action of chiral catalyst,
isobutene and diazoacetate are subjected to cyclopropanation reaction in a halogenated
hydrocarbon solvent at -25-25C for 2-3 h. (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate
is obtained by acid washing, alkali washing, and distillation sequentially.
(2) Catalytic amidation of (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate. Specifically,
(S)-(+)-2,2- dimethyl cyclopropanecarboxylate and a catalyst are respectively weighed,
wherein the mass ratio of catalyst to (S)-(+)-2,2-dimethyl cyclopropanecarboxylate is 0.01
0.09:1. Under the action of catalyst, (S)-(+)-2,2-dimethyl cyclopropanecarboxylate
undergoes ammonolysis reaction in an alcohol solution of ammonia at 25-120 °C for24
h. The (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide is obtained by desolvation,
extraction and re-desolvation.
(3) Purification of (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide. Crystallize (S)-(+)-2,
2- dimethyl cyclopropanecarboxamide with alcohol or a mixture of alcohol and acid.
Wherein, the alcohol is selected from any one of methanol, ethanol, propanol and n
butanol, and the acid is selected from any one of formic acid, acetic acid, propionic acid,
L-tartaric acid, L-malic acid, L-DTTA and L-mandelic acid. The chemical purity of refined
(S)-(+)-2, 2- dimethyl cyclopropanecarboxamide is higher than 99.5% and e.e. value is
greater than 99.5%.
Further, the carboxyl group in the diazoacetate is selected from C1-C6 alkyl or benzyl.
Specifically, the C1-C6 alkyl group is methyl, ethyl, isopropyl, tert-butyl, or benzyl.
Further, in the step (1), in the asymmetric cyclopropanation reaction, the chiral copper
reagent used is a complex formed by cuprous salt and chiral ligand, and the haloalkane
reagent is monohalogenated or polyhalogenated alkane of C1-C4.
Further, in step (1), the cuprous salt is selected from any one of cuprous chloride, cuprous
bromide, cuprous iodide, cuprous trifluoroacetate or cuprous trifluoromethanesulfonate,
and the chiral ligand is selected from (R,R)-(+)-2,2'-isopropylidenebis (4-tert-butyl-2
oxazoline), (R,R)-(+)-2,2'-isopropylidenebis (4-phenyl-2-oxazoline), (R,R)-(+)-2,2'
isopropylidenebis (4-benzyl-2-oxazoline) and (R,R)-(+)-2,2'-isopropylidenebis (4
isopropyl-2-oxazoline).
Further, the haloalkane reagent is monohalogenated or polyhalogenated alkane of C1-C4,
specifically selected from any one of dichloromethane, chloroform, 1,2-dichloroethane,
chloropropane or chlorobutane.
Further, in the step (2), catalytic amidation reaction, the alcohol used is C1-C6 aliphatic
alcohol selected from any one of methyl alcohol, ethanol, propanol, isopropanol and n
butanol, and the catalyst is Lewis acid selected from any one of magnesium chloride,
aluminum chloride, cobalt chloride, calcium chloride, nickel chloride and ferric chloride.
Further, in the alcohol solution of ammonia, the volume ratio of ammonia to alcohol is 1:
1-10, preferably a saturated alcohol solution of ammonia.
Further, in step (3), the alcohol is selected from any one of methanol, ethanol, propanol
and n-butanol, and the acid is selected from any one of formic acid, acetic acid, propionic
acid, L-tartaric acid, L-malic acid, L-DTTA and L-mandelic acid, and its concentration ranges from 0.5 to 3 mol/L. Specifically, in the step (3), when the alcohol and the acid are mixed, the volume ratio of the alcohol to the acid is 1: 0.5-1: 2.
Further, in step (1), the acid is an aqueous solution of any one of sulfuric acid, hydrochloric
acid, acetic acid and phosphoric acid, with concentration ranges from 0.5 to 3 mol/L.
Besides, the alkali is an aqueous solution of any one of sodium carbonate, potassium
carbonate, sodium bicarbonate, and potassium bicarbonate, with a concentration range of
between 0.5 and 3 mol/L.
The synthetic route of the invention is as follows:
+ N 2CH 2C0 2Et cat H cat.H 2 3 'CO 2 Et NH3 'CONH 2
The principle of the invention is as follows. Diazoacetate is prepared by diazotization of
glycine ester hydrochloride. And then diazoacetate and isobutene are catalyzed by chiral
ligand complex of cuprous salt, and then (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate is
obtained by cyclopropylation. (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide is directly
synthesized by one-step ammonolysis of (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate.
The chemical purity of refined amide by alcohol is higher than 99.5% and e.e. value is
greater than 99.5% as well.
The method disclosed by the invention is a green, environment-friendly, simple and
efficient method for synthesizing (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide, with
the e.e. value greater than 99.5 %.
Figure 1 is the HNMR spectrum of (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide
obtained from Embodiments 1-9.
Specific embodiments and figures will further illustrate the present invention, but it is not
limited to this.
Embodiment 1
+ N2 CH 2 C0 2 Et cat.
The method for preparing the (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate specifically
comprises the following steps.
Add (R,R)-(+)-2,2'-isopropylidenebis (4-tert-butyl-2-oxazoline) (1.74 g, 5.94 mmol),
cuprous trifluoromethanesulfonate (1.14 g, 5.4 mmol) and dichloromethane (250 ml) into
a 1000 ml three-neck flask with a thermometer and dropping funnel, and stir for 2 h at room
temperature (25-30°C). The reaction system was then cooled to -5 - 0 °C and isobutylene
was added to saturate, and then ethyl diazoacetate (114 g, 1 mol) was added slowly. The
temperature of the reaction system was controlled to 0 °C, and then the system was slowly
heated to room temperature (25 °C) and stirred for 1 h. After TLC detected the EDA
consumption, the system was depressurized and concentrated (T < 30 °C, - 0.09 MPa) to
obtain the crude product. Finally, 90 g of main distillate fraction was obtained by vacuum
distillation of crude product, with GC > 98 %, e.e. value > 95%.
Embodiment 2
+ N 2CH 2 CO2 i-Pr cat. H 'CO2i-Pr
The method for preparing the (S)-(+)-2, 2-isopropyl dimethyl cyclopropanecarboxylate
specifically comprises the following steps.
Add (R,R)-(+)-2,2'-isopropylidenebis (4-tert-butyl-2-oxazoline) (1.74 g, 5.94 mmol),
cuprous trifluoromethanesulfonate (1.14 g, 5.4 mmol) and dichloromethane (250 ml) into
a 1000 ml three-neck flask with thermometer and dropping funnel, and stir for 2 h at room
temperature (25-30 °C). The reaction system was then cooled to -5 - 0 °C and isobutylene
was added to saturate, and then isopropyl diazoacetate (129 g, 1 mol) was added slowly.
The temperature of the reaction system was controlled to 0 °C, and then the system was
slowly heated to room temperature (25 °C) and stirred for 1 h. After the TLC detected the
EDA consumption, the system was depressurized and concentrated (T < 30 °C, - 0.09 MPa)
to obtain the crude product. Finally, 100 g of main distillate fraction was obtained by
vacuum distillation of crude product, with GC > 98 %, e.e. value > 95%.
Embodiment 3
cat. H + N 2CH 2 CO 2Me 'CO Me 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxylate specifically
comprises the following steps.
Add (R,R)-(+)-2,2'-isopropylidenebis (4-tert-butyl-2-oxazoline) (1.74 g, 5.94 mmol),
cuprous trifluoromethanesulfonate (1.14 g, 5.4 mmol) and dichloromethane (250 ml) into
a 1000 ml three-neck flask with thermometer and dropping funnel, and stir for 2 h at room
temperature (25-30 °C). The reaction system was then cooled to -5 - 0 °C and isobutylene
was added to saturate, and then methyl diazoacetate (101 g, 1 mol) was added slowly. The
temperature of the reaction system was controlled to 0 °C, and then the system was slowly
heated to room temperature (25 °C) and stirred for 1 h. After the TLC detected the EDA
consumption, the system was depressurized and concentrated (T < 30 °C, - 0.09 MPa) to obtain the crude product. Finally, 88 g of main distillate fraction was obtained by vacuum distillation of crude product, with GC > 98 %, e.e. value > 95%.
Embodiment 4
+ N 2 CH 2 CO2 Et cat >EH
The method for preparing the (S)-(+)-2, 2- ethyl dimethyl cyclopropanecarboxylate
specifically comprises the following steps.
Add (R,R)-(+)-2,2'-isopropylidenebis (4-phenyl-2-oxazoline) (1.98 g, 5.94 mmol), cuprous
trifluoromethanesulfonate (1.14 g, 5.4 mmol) and dichloromethane (250 ml) into a 1000
ml three-neck flask with thermometer and dropping funnel, and stir for 2 h at room
temperature (25-30 °C). The reaction system was then cooled to -5 - 0 °C and isobutylene
was added to saturate, and then ethyl diazoacetate (114 g, 1 mol) was added slowly. The
temperature of the reaction system was controlled to 0 °C, and then the system was slowly
heated to room temperature (25 °C) and stirred for 1 h. After the TLC detected the EDA
consumption, the system was depressurized and concentrated (T < 30 °C, - 0.09 MPa) to
obtain the crude product. Finally, 92 g of main distillate fraction was obtained by vacuum
distillation of crude product, with GC > 98 %, e.e. value > 95%.
Embodiment 5
+ N 2 CH 2 CO2 Et cat 0
The method for preparing the (S)-(+)-2, 2- ethyl dimethyl cyclopropanecarboxylate
specifically comprises the following steps.
Add (R,R)-(+)-2,2'-isopropylidenebis (4-benzyl-2-oxazoline) (2.15 g, 5.94 mmol), cuprous
trifluoromethanesulfonate (1.14 g, 5.4 mmol) and dichloromethane (250 ml) into a 1000
ml three-neck flask with a thermometer and dropping funnel, and stir for 2 h at room
temperature (25-30 °C). The reaction system was then cooled to -5 - 0 °C and isobutylene
was added to saturate, and then ethyl diazoacetate (114 g, 1 mol) was added slowly. The
temperature of the reaction system was controlled to 0 °C, and then the system was slowly
heated to room temperature (25 °C) and stirred for 1 h. After the TLC detected the EDA
consumption, the system was depressurized and concentrated (T < 30 °C, - 0.09 MPa) to
obtain the crude product. Finally, 89 g of main distillate fraction was obtained by vacuum
distillation of crude product, with GC > 98 %, e.e. value > 95%.
Embodiment 6
+ N 2 CH 2 CO2 Et cat 02Et
The method for preparing the (S)-(+)-2, 2- ethyl dimethyl cyclopropanecarboxylate
specifically comprises the following steps.
Add (R,R)-(+)-2,2'-isopropylidenebis (4-tert-butyl-2-oxazoline) (1.74 g, 5.94 mmol),
cuprous chloride (0.54 g, 5.4 mmol) and dichloromethane (250 ml) into a 1000 ml three
neck flask with thermometer and dropping funnel, and stir for 2 h at room temperature (25
°C). The reaction system was then cooled to -5 - 0 °C and isobutylene was added to
saturate, and then ethyl diazoacetate (114 g, 1 mol) was added slowly. The temperature of
the reaction system was controlled to 0 °C, and then the system was slowly heated to room
temperature (25 °C) and stirred for 1 h. After the TLC detected the EDA consumption, the
system was depressurized and concentrated (T < 30 °C, - 0.09 MPa) to obtain the crude product. Finally, 93g of main distillate fraction was obtained by vacuum distillation of crude product, with GC > 98 %, e.e. value > 93%.
Embodiment 7
+ N 2 CH 2 CO2 Et cat >EH
The method for preparing the (S)-(+)-2, 2- ethyl dimethyl cyclopropanecarboxylate
specifically comprises the following steps.
Add (R,R)-(+)-2,2'-isopropylidenebis (4-tert-butyl-2-oxazoline) (1.74 g, 5.94 mmol),
cuprous iodide (1.03 g, 5.4 mmol) and dichloromethane (250 ml) into a 1000 ml three-neck
flask with thermometer and dropping funnel, and stir for 2 h at room temperature (25-30
°C). The reaction system was then cooled to -5 - 0 °C and isobutylene was added to
saturate, and then ethyl diazoacetate (114 g, 1 mol) was added slowly. The temperature of
the reaction system was controlled to 0 °C, and then the system was slowly heated to room
temperature (25 °C) and stirred for 1 h. After the TLC detected the EDA consumption, the
system was depressurized and concentrated (T < 30 °C, - 0.09 MPa) to obtain the crude
product. Finally, 97 g of main distillate fraction was obtained by vacuum distillation of
crude product, with GC > 98 %, e.e. value > 94%.
Embodiment 8
+ N 2 CH 2 CO2 Et cat 0
The method for preparing the (S)-(+)-2, 2- ethyl dimethyl cyclopropanecarboxylate
specifically comprises the following steps.
Add (R,R)-(+)-2,2'-isopropylidenebis (4-tert-butyl-2-oxazoline) (1.74 g, 5.94 mmol),
cuprous iodide (1.03 g, 5.4 mmol) and dichloromethane (250 ml) into a 1000 ml three-neck
flask with thermometer and dropping funnel, and stir for 2 h at room temperature (25-30
°C). The reaction system was then cooled to -25 °C and isobutylene was added to saturate,
and then ethyl diazoacetate (114 g, 1 mol) was added slowly. The temperature of the
reaction system was controlled to -25 °C, and then the system was stirred for 3 h. After the
TLC detected the EDA consumption, the system was depressurized and concentrated (T <
°C, - 0.09 MPa) to obtain the crude product. Finally, 87 g of main distillate fraction was
obtained by vacuum distillation of crude product, with GC > 98 %, e.e. value > 96%.
Embodiment 9
+ N2 CH 2 CO2 Et cat >EH
The method for preparing the (S)-(+)-2, 2- ethyl dimethyl cyclopropanecarboxylate
specifically comprises the following steps.
Add (R,R)-(+)-2,2'-isopropylidenebis (4-tert-butyl-2-oxazoline) (1.74 g, 5.94 mmol),
cuprous iodide (1.03 g, 5.4 mmol) and dichloromethane (250 ml) into a 1000 ml three-neck
flask with thermometer and dropping funnel, and stir for 2 h at room temperature (25-30
°C). The reaction system was then cooled to -20 - 25 °C and isobutylene was added to
saturate, and then ethyl diazoacetate (114 g, 1 mol) was added slowly. The temperature
of the reaction system was controlled to 20-25 °C, and then the system was stirred for 1 h.
After the TLC detected the EDA consumption, the system was depressurized and
concentrated (T < 30 °C, - 0.09 MPa) to obtain the crude product. Finally, 102 g of main distillate fraction was obtained by vacuum distillation of crude product, with GC > 98 %, e.e. value > 94%.
Embodiment 10
H NH 3 , cat. H 'CO 2 Me ''CONH 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide specifically
comprises the following steps.
Add (S)-(+)-2, 2- dimethyl cyclopropanecarboxylate (12.8 g, 0.1 mol), anhydrous calcium
chloride (13.3 g, 0.12 mmol) and methanol ammonia (140 ml, ammonia saturated solution
prepared at 0 -5 °C) into a 250 ml autoclave. When the temperature raised to 100 -110 °C
, stirring 18-20 h for reaction. After reducing to room temperature, the reaction solution
was concentrated under reduced pressure, and then water (30 ml) was added to raise the
temperature and reflux. After dissolving and clarifying, the reaction solution was reduced
to room temperature and stirred in ice water bath for 1 h. The white solid precipitated and
filtered out. The aqueous phase was extracted with ethyl acetate (50 ml * 2) and the organic
phase was concentrated to obtain a total of 9 g solid with e.e. > 95%.
Embodiment 11
H NH3, cat. H 'CO 2 Me 'CONH 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide specifically
comprises the following steps.
Add (S)-(+)-2, 2- dimethyl cyclopropanecarboxylate (14.2 g, 0.1 mol), anhydrous calcium
chloride (13.3 g, 0.12 mmol) and methanol ammonia (140 ml, ammonia saturated solution
prepared at 0 -5 °C) into a 250 ml autoclave. When the temperature raised to 100 -110 °C stirring 18-20 h for reaction. After reducing to room temperature, the reaction solution was concentrated under reduced pressure, and then water (30 ml) was added to raise the temperature and reflux. After dissolving and clarifying, the reaction solution was reduced to room temperature and stirred in ice water bath for 1 h. The white solid precipitated and filtered out. The aqueous phase was extracted with ethyl acetate (50 ml * 2) and the organic phase was concentrated to obtain a total of 10 g solid with e.e. > 95%.
Embodiment 12
H NH 3 , cat. H 'CO 2 Me ''CONH 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide specifically
comprises the following steps.
Add (S)-(+)-2, 2- dimethyl cyclopropanecarboxylate (15.6 g, 0.1 mol), anhydrous calcium
chloride (13.3 g, 0.12 mmol) and methanol ammonia (140 ml, ammonia saturated solution
prepared at 0 -5 °C) into a 250 ml autoclave. When the temperature raised to 100 -110
°C, stirring 18-20 h for reaction. After reducing to room temperature, the reaction solution
was concentrated under reduced pressure, and then water (30 ml) was added to raise the
temperature and reflux. After dissolving and clarifying, the reaction solution was reduced
to room temperature and stirred in ice water bath for 1 h. The white solid precipitated and
filtered out. The aqueous phase was extracted with ethyl acetate (50 ml * 2) and the organic
phase was concentrated to obtain a total of 10 g solid with e.e. > 95%.
Embodiment 13
H NH 3 , cat. H ''CO 2 Me ''CONH 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide specifically
comprises the following steps.
Add (S)-(+)-2, 2- dimethyl cyclopropanecarboxylate (12.8 g, 0.1 mol), anhydrous calcium
chloride (15.6 g, 0.12 mmol) and methanol ammonia (140 ml, ammonia saturated solution
prepared at 0 -5 °C) into a 250 ml autoclave. When the temperature raised to 100 -110
°C, stirring 18-20 h for reaction. After reducing to room temperature, the reaction solution
was concentrated under reduced pressure, and then water (30 ml) was added to raise the
temperature and reflux. After dissolving and clarifying, the reaction solution was reduced
to room temperature and stirred in ice water bath for 1 h. The white solid precipitated and
filtered out. The aqueous phase was extracted with ethyl acetate (50 ml * 2) and the organic
phase was concentrated to obtain a total of 8 g solid with e.e. > 95%.
Embodiment 14
H NH 3 , cat. H 'CO 2 Me 'CONH 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide specifically
comprises the following steps.
Add (S)-(+)-2, 2- Dimethyl cyclopropanecarboxylate (12.8 g, 0.1 mol), anhydrous calcium
chloride (15.6 g, 0.12 mmol) and methanol ammonia (140 ml, ammonia saturated solution
prepared at 0 -5 °C) into a 250 ml autoclave. When the temperature raised to 100 -110 °C
, stirring 18-20 h for reaction. After reducing to room temperature, the reaction solution
was concentrated under reduced pressure, and then water (30 ml) was added to raise the
temperature and reflux. After dissolving and clarifying, the reaction solution was reduced
to room temperature and stirred in ice water bath for 1 h. The white solid precipitated and filtered out. The aqueous phase was extracted with ethyl acetate (50 ml * 2) and the organic phase was concentrated to obtain a total of 8 g solid with e.e. > 95%.
Embodiment 15
H NH 3 , cat. H 'CO 2 Me ''CONH 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide specifically
comprises the following steps.
Add (S)-(+)-2, 2- dimethyl cyclopropanecarboxylate (12.8 g, 0.1 mol), anhydrous
magnesium chloride (11.4 g, 0.12 mmol) and methanol ammonia (140 ml, ammonia
saturated solution prepared at 0 -5 °C) into a 250 ml autoclave. When the temperature
raised to 100 -110 °C, stirring 18-20 h for reaction. After reducing to room temperature,
the reaction solution was concentrated under reduced pressure, and then water (30 ml) was
added to raise the temperature and reflux. After dissolving and clarifying, the reaction
solution was reduced to room temperature and stirred in ice water bath for 1 h. The white
solid precipitated and filtered out. The aqueous phase was extracted with ethyl acetate (50
ml * 2) and the organic phase was concentrated to obtain a total of 9 g solid with e.e. >
Embodiment 16
H NH 3 , cat. H ''CO 2 Me ''CONH 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide specifically
comprises the following steps.
Add (S)-(+)-2, 2- dimethyl cyclopropanecarboxylate (12.8 g, 0.1 mol), anhydrous cobalt
chloride (15.5 g, 0.12 mmol) and methanol ammonia (140 ml, ammonia saturated solution prepared at 0 -5 °C) into a 250 ml autoclave. When the temperature raised to 100 -110 °C
, stirring 18-20 h for reaction. After reducing to room temperature, the reaction solution
was concentrated under reduced pressure, and then water (30 ml) was added to raise the
temperature and reflux. After dissolving and clarifying, the reaction solution was reduced
to room temperature and stirred in ice water bath for 1 h. The white solid precipitated and
filtered out. The aqueous phase was extracted with ethyl acetate (50 ml * 2) and the organic
phase was concentrated to obtain a total of 9 g solid with e.e. > 95%.
Embodiment 17
AA H NH3, cat. H 'CO 2 Me 'CONH 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide specifically
comprises the following steps.
Add (S)-(+)-2, 2- dimethyl cyclopropanecarboxylate (12.8 g, 0.1 mol), anhydrous
magnesium chloride (11.4 g, 0.12 mmol) and methanol ammonia (140 ml, ammonia
saturated solution prepared at 0 -5 °C) into a 250 ml autoclave. Stirring 18-20 h for reaction
at room temperature. After reducing to room temperature, the reaction solution was
concentrated under reduced pressure, and then water (30 ml) was added to raise the
temperature and reflux. After dissolving and clarifying, the reaction solution was reduced
to room temperature and stirred in ice water bath for 1 h. The white solid precipitated and
filtered out. The aqueous phase was extracted with ethyl acetate (50 ml * 2) and the organic
phase was concentrated to obtain a total of 6 g solid with e.e. > 95%.
Embodiment 18
H NH 3 , cat. H 'CO2 Me ''CONH 2
The method for preparing the (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide specifically
comprises the following steps.
Add (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate (12.8 g, 0.1 mol), anhydrous
magnesium chloride (11.4 g, 0.12 mmol) and methanol ammonia (140 ml, ammonia
saturated solution prepared at 0-5 °C) into a 250 ml autoclave. When the temperature raised
to 50-60 °C, stirring 18-20 h for reaction. After reducing to room temperature, the reaction
solution was concentrated under reduced pressure, and then water (30 ml) was added to
raise the temperature and reflux. After dissolving and clarifying, the reaction solution was
reduced to room temperature and stirred in ice water bath for 1 h. The white solid
precipitated and filtered out. The aqueous phase was extracted with ethyl acetate (50 ml*
2) and the organic phase was concentrated to obtain a total of 8 g solid with e.e. > 95%.
Embodiment 19
The method for purifying the above-mentioned (S)-(+)-2, 2- dimethyl
cyclopropanecarboxamide specifically comprises the following steps.
Ina 100 ml three-neck flask with a thermometer and a dropping funnel, 5 g crudeproduct
of (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide and 15 ml of methanol were added,
heated and refluxed for 1 h, cooled gradually (within 3 h) to room temperature, stirred for
1 h, and filtered to obtain 3.5 g of white solid with a yield of 75% and an e.e. value of
higher than 99.5%.
Avance 500 MHz nuclear magnetic spectrometer and Dionex MSOPlus mass spectrometer
were used to determine the white solid. The results of NMR and MS data are as follows:
1H NMR (500 MHz, CDCl3) 6 7.42 (br, 1H), 6.68 (br, 1H), 1.33 (dd, J= 7.7, 5.4 Hz, 1H),
1.09 (s, 6H), 0.88 (t, J = 4.6 Hz, 1H), 0.70 (dd, J = 7.7, 4.3 Hz, 1H). ESI-MS(m/z): 114.3
(M+1)+.
Furthermore, the NMR spectrum is shown in Fig. 1;
From the above NMR data, MS data and NMR spectra, it can be concluded that the
structural formula of the white solid obtained above is as follows:
s)''CONH2, that is, (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide
Embodiment 20
The method for purifying the above-mentioned (S)-(+)-2, 2- dimethyl
cyclopropanecarboxamide specifically comprises the following steps.
Ina 100 ml three-neck flask with a thermometer and a dropping funnel, 5 g crudeproduct
of (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide, 10 ml of methanol and 1 ml acetic
acid were added, heated and refluxed for 1 h, cooled gradually (within 3 h) to room
temperature, stirred for 1 h, and filtered to obtain 4.5 g of white solid with a yield of 90%
and an e.e. value of more than 99.5%.
From the NMR data, MS data and NMR spectra, it can be concluded that the structural
formula of the white solid obtained above is as follows:
>'YCnVH (s)'CONH2, namely, (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide
Embodiment 21
The method for purifying the above-mentioned (S)-(+)-2, 2- dimethyl
cyclopropanecarboxamide specifically comprises the following steps.
Ina 100 ml three-neck flask with a thermometer and a dropping funnel, 5 g crudeproduct
of (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide, 10 ml ethanol and 1 ml acetic acid
were added, heated and refluxed for 1 h, cooled gradually (within 3 h) to room temperature,
stirred for 1 h, and filtered to obtain 4.6 g of white solid with a yield of 95% and an e.e.
value of more than 99.5%.
From the above NMR data, MS data and NMR spectra, it can be concluded that the
structural formula of the white solid obtained above is as follows:
(s)''CONH2, namely, (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide
Embodiment 22
The method for purifying the above-mentioned (S)-(+)-2, 2- dimethyl
cyclopropanecarboxamide specifically comprises the following steps.
Ina 100 ml three-neck flask with a thermometer and a dropping funnel, 5 g crudeproduct
of (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide and 10 ml isopropanol and 1 ml acetic
acid were added, heated and refluxed for 1 h, cooled gradually (within 3 h) to room
temperature, stirred for 1 h, and filtered to obtain 4.6 g of white solid with a yield of 92%
and an e.e. value of more than 99.5%.
From the above NMR data, MS data and NMR spectra, it can be concluded that the
structural formula of the white solid obtained above is as follows:
>'YCnVH s)''CONH2, that is, (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide
The above embodiments are only used to illustrate the present invention and are not used
to limit the scope of the present invention. In addition, after reading the present invention,
those skilled in the field can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of this application.
Claims (2)
1. A preparation method of (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide, characterized
by comprising the following steps.
(1) Preparation of (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate. Weighing isobutylene
and diazoacetate, wherein the carboxyl group in the diazoacetate is selected from C1-C6
alkyl or benzyl, and the molar ratio of isobutylene to diazoacetate is 0.8-1.2: 0.8-1.
2. Then
weighing chiral catalyst, which is a complex formed by cuprous salt and chiral ligand.
Further, the cuprous salt is selected from any one of cuprous chloride, cuprous bromide,
cuprous iodide, cuprous trifluoroacetate or cuprous trifluoromethanesulfonate, and the
chiral ligand is selected from (R,R)-(+)-2,2'-isopropylidenebis (4-tert-butyl-2-oxazoline),
(R,R)-(+)-2,2'-isopropylidenebis (4-phenyl-2-oxazoline), (R,R)-(+)-2,2'-isopropylidenebis
(4-benzyl-2-oxazoline) and (R,R)-(+)-2,2'-isopropylidenebis (4-isopropyl-2-oxazoline).
Besides, the addition amount of the chiral catalyst is 0.5-3% of the mass of isobutylene.
And then the halogenated hydrocarbon solvent is measured, which is anyone selected from
dichloromethane, chloroform, 1,2-dichloroethane, chloropropane or chlorobutane. The
volume ratio of halogenated hydrocarbon solvent to isobutene is 1-3: 1. Chiral catalyst is
added into a reaction vessel, then halogenated hydrocarbon solvent and isobutene are
added, and diazoacetate is finally added. Under the action of chiral catalyst, isobutene and
diazoacetate are subjected to cyclopropanation reaction in halogenated hydrocarbon
solvent at -25-25C for 2-3 h. (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate is obtained
by acid washing, alkali washing and distillation sequentially. Wherein, the acid is an
aqueous solution of any one of sulfuric acid, hydrochloric acid, acetic acid and phosphoric acid, and the alkali is an aqueous solution of any one of sodium carbonate, potassium carbonate, sodium bicarbonate and potassium bicarbonate.
(2) Catalytic amidation of (S)-(+)-2, 2-dimethyl cyclopropanecarboxylate. Specifically,
(S)-(+)-2,2- dimethyl cyclopropanecarboxylate and a catalyst are respectively weighed,
wherein the catalyst is Lewis acid selected from any one of magnesium chloride, aluminum
chloride, cobalt chloride, calcium chloride, nickel chloride and ferric chloride. The mass
ratio of catalyst to (S)-(+)-2,2- dimethyl cyclopropanecarboxylate is 0.01-0.09:1. Under
the action of catalyst, (S)-(+)-2,2- dimethyl cyclopropanecarboxylate undergoes
ammonolysis reaction in an alcohol solution of ammonia, wherein the alcohol used is Cl
C6 aliphatic alcohol, and the volume ratio of ammonia to alcohol in the alcohol solution of
ammonia is 1: 1-10. The reaction temperature is 25-120 °C and the reaction time is 24
h. The (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide is obtained by desolvation,
extraction and re-desolvation.
(3) Purification of (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide. Crystallize (S)-(+)-2,
2- dimethyl cyclopropanecarboxamide with alcohol or mixture of alcohol and acid.
Wherein, the alcohol is selected from any one of methanol, ethanol, propanol and n
butanol, and the acid is selected from any one of formic acid, acetic acid, propionic acid,
L-tartaric acid, L-malic acid, L-DTTA and L-mandelic acid. The chemical purity of refined
(S)-(+)-2, 2- dimethyl cyclopropanecarboxamide is higher than 99.5% and e.e. value is
greater than 99.5% as well.
- 08 Feb 2021
-1/1- 2021100766
Figure 1
The HNMR spectrum of (S)-(+)-2, 2- dimethyl cyclopropanecarboxamide obtained from
Embodiments 1-9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021100766A AU2021100766A4 (en) | 2021-02-08 | 2021-02-08 | A Preparation Method of (S)-(+)-2, 2-dimethyl cyclopropanecarboxamide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021100766A AU2021100766A4 (en) | 2021-02-08 | 2021-02-08 | A Preparation Method of (S)-(+)-2, 2-dimethyl cyclopropanecarboxamide |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021100766A4 true AU2021100766A4 (en) | 2021-04-22 |
Family
ID=75502426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021100766A Ceased AU2021100766A4 (en) | 2021-02-08 | 2021-02-08 | A Preparation Method of (S)-(+)-2, 2-dimethyl cyclopropanecarboxamide |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021100766A4 (en) |
-
2021
- 2021-02-08 AU AU2021100766A patent/AU2021100766A4/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2659091C (en) | A process for the preparation of optically active cyclopropylamines | |
CA2396090C (en) | Asymmetric synthesis of pregabalin | |
Hamashima et al. | Highly enantioselective fluorination reactions of β-ketoesters and β-ketophosphonates catalyzed by chiral palladium complexes | |
AU2009256959B2 (en) | Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | |
CN103387541A (en) | Preparation method of substituted pyrazolylether compound | |
KR101821090B1 (en) | Process for manufacture of n-acylbiphenyl alanine | |
CA2769960C (en) | Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | |
CN114163375B (en) | Synthesis method of 6,6-dimethyl-3-azabicyclo [3.1.0] hexane or derivative thereof | |
CN106458853B (en) | Method for preparing sitagliptin intermediate by asymmetric reduction method | |
CN109232311A (en) | A kind of Pregabalin synthetic method of green high-efficient | |
AU2021100766A4 (en) | A Preparation Method of (S)-(+)-2, 2-dimethyl cyclopropanecarboxamide | |
Liu et al. | Catalytic asymmetric transformation of nitrones and allenes to dihydropyridoindoles via chiral N, N′-dioxide/cobalt (ii) catalysis | |
CN104193645B (en) | Preparation method of chiral dimethyl cyclopropyl carboxamide | |
CN107674016B (en) | Preparation method of telaprevir intermediate and intermediate thereof | |
CN114315609A (en) | Process for preparing cis-2-aminocyclohexanol | |
CN113135857A (en) | Synthesis method of N-hydroxyethyl-5-amino-1H pyrazole | |
EP2327685B1 (en) | Process for production of alpha-trifluoromethyl- beta-substituted- beta -amino acid | |
CN115784916B (en) | Method for preparing 2- (S) -amino-4-arylbutyric acid compound | |
KR100413172B1 (en) | A process for the preparation of quinolinone derivatives | |
JP2009242243A (en) | alpha-HYDROXYIMINO CARBOXYLIC ACID ESTER DERIVATIVE AND METHOD FOR PRODUCING alpha-AMINO-alpha-HALOALKYL CARBOXYLIC ACID ESTER DERIVATIVE BY USING THE SAME | |
US20030045748A1 (en) | Process for the preparation of ethers deriving from hydroxybenzoic acids | |
US6175024B1 (en) | Synthesis of functionalized esters | |
KR20020038466A (en) | A process for the preparation of carbostyryl derivatives | |
CN118221606A (en) | Cilastatin sodium intermediate compound and preparation method thereof | |
CN116410095A (en) | Synthesis method of phenylephrine hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) | ||
MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |